PAS
USNA icon

Point72 Asia (Singapore)’s Usana Health Sciences USNA Stock Holding History

Point72 Asia (Singapore)’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-271
Closed -$12.2K – 1342
2024
Q2 		$12.2K Sell
271
-562
-67% -$25.9K ﹤0.01% 904
2024
Q1 		$40.4K Buy
+833
New +$40.8K 0.01% 836

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Point72 Asia (Singapore)'s USNA Position: Q3 2024 in Review

Point72 Asia (Singapore) sold out of Usana Health Sciences (USNA) in Q3 2024, closing a stake of 271 shares — an estimated $12.2K sold.

Point72 Asia (Singapore) first reported a position in USNA in Q1 2024 and held it in 2 quarters. The position peaked at $40.4K in Q1 2024. 147 funds tracked by Wall St. Rank hold USNA as of Q3 2024.

  • Point72 Asia (Singapore) reported no remaining Usana Health Sciences position as of Q3 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 271 Usana Health Sciences shares in Q3 2024, an estimated $12.2K.
  • Point72 Asia (Singapore) first reported a position in Usana Health Sciences in Q1 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Usana Health Sciences position peaked at $40.4K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2024, filed 14 Nov 2024.